New RA Guidelines Emphasize Early Identification, Treatment

Dr. Paul Emery

In an editorial accompanying the guidelines in the Annals of the Rheumatic Diseases, ACR President Stanley Cohen and EULAR President Paul Emery said that the 1987 criteria, although useful for differentiating “established” RA from other rheumatologic diseases, are “widely regarded as unsatisfactory for the diagnosis of RA (for which they were not designed)” (Ann. Rheum. Dis. 2010;69:1575-6).

However, in 2010, “the need for the new classification criteria has been made more urgent by the understanding that, at presentation, RA may be an evolving disease, the final phenotype of which can be altered by interventions.”

And despite the fact that “change can be difficult for a generation of rheumatologists used to classifying RA with the old criteria,” the authors were hopeful that “these new classification criteria will be rapidly adopted in daily practice, and we look forward to their implementation in clinical trials.”

Indeed, they added, “How these criteria might impact patient selection for clinical trials will be of great interest.”

Dr. Cohen is affiliated with the clinical research center at the University of Texas Southwestern Medical School in Dallas. Dr. Emery is from the University of Leeds (England). Both stated that they had no competing interests to disclose in relation to this editorial.